77% of drugs in Shanghai are no longer limited by bidding price

Source: saibelan December 9, 2014, Shanghai Price Bureau, health and Family Planning Commission and medical insurance office officially issued a notice to liberalize the price of drugs priced by non-government All kinds of drugs other than those priced by the government, including the medical institutions that independently produce hospital preparations, shall be subject to market price adjustment, and the drug production and marketing enterprises shall independently price them according to the operation of the enterprises or medical institutions At present, China has three pricing forms for drugs: drugs included in the reimbursement catalogue of basic medical insurance and a few drugs with monopoly production and operation, which are priced by the government or guided by the government Among them, there are about 100 kinds of drugs purchased by the government for free and distributed to specific groups, which are priced by the government At present, there are about 0.8% of the approved drugs on the market; other drugs are priced by the government, which is the highest retail price limit, which is about 2600 kinds, accounting for about 22% In addition to the 2700 kinds of drugs priced and guided by the government, the other 77% Most of the drugs are not priced by the government They can be adjusted by the market and priced by the enterprises themselves However, they still need to go to the price department for the record In the actual implementation process, many places have set up thresholds, which to some extent become a disguised administrative approval, which restricts the decision right of the enterprises to their own product prices Therefore, after Shanghai's decentralization, the enterprises have realized the full independent pricing On the purchase of these drugs, the notice said that the designated medical institutions of municipal medical insurance shall purchase the drugs with market adjusted price through Internet according to the relevant provisions of the Municipal Drug Centralized Purchase Department, and the relevant drug production and marketing enterprises must report the specific information of the drugs to the Municipal Drug Centralized Purchase work institutions, and the specific measures shall be formulated separately The designated medical institutions of medical insurance in this Municipality may follow the drug markup rate not exceeding that prescribed by the state and this Municipality Senior insiders of the industry told saibelan that it is more important for Shanghai to liberalize the price of drugs that enterprises do not need to go through the bidding control procedures after entering the hospital (the competent bidding Department determines the catalogue, bids, bids, bid evaluation, bid opening and many other control links) This will be a big deregulation for enterprises In the past, although these drugs were priced independently, if they are to be sold in hospitals, they must go through the government led bidding control After the opening and opening of the Internet, the market will play a greater role Companies can compete for price and quality However, at the same time, senior insiders pointed out that as medical institutions are still selling according to the markup rate stipulated by the state and the city, they may face a dilemma for enterprises On the one hand, there is fierce competition after Internet access To let medical institutions buy their own drugs, it is obvious that they need high quality and good price On the other hand, the markup rate control will make medical institutions tend to high price drugs How to balance the two is a problem In order to give full play to the decisive role of the market in the allocation of drug resources, it is necessary to cancel the control of the markup rate, not to limit or cancel the markup rate Once there is a price increase rate control, it will make the high price drugs be favored For example, if there is no price increase rate control, the hospital will buy a box of cold medicine for 1 yuan, sell it for 2.5 yuan, and the hospital will earn 1.5 yuan (the price increase rate is 150%); if the price increase rate of the hospital is limited, the hospital can only add 15% on the basis of the purchase price If the hospital wants to earn 1.5 yuan, the purchase price of the same box of cold medicine must be 10 yuan, and sell it for 11.5 yuan Yuan For consumers, it is obvious that the price of cold medicine is much higher.